Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab
Niño-Taravilla, C.; Espinosa-Vielma, Y.P.; Otaola-Arca, H.; Poli-Harlowe, C.; Tapia, L.I.; Ortiz-Fritz, P. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab. Pediatr. Rep. 2020, 12, 142-148. https://doi.org/10.3390/pediatric12030029
Niño-Taravilla C, Espinosa-Vielma YP, Otaola-Arca H, Poli-Harlowe C, Tapia LI, Ortiz-Fritz P. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab. Pediatric Reports. 2020; 12(3):142-148. https://doi.org/10.3390/pediatric12030029
Chicago/Turabian StyleNiño-Taravilla, Carmen, Yazmín P. Espinosa-Vielma, Hugo Otaola-Arca, Cecilia Poli-Harlowe, Lorena I. Tapia, and Paula Ortiz-Fritz. 2020. "Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab" Pediatric Reports 12, no. 3: 142-148. https://doi.org/10.3390/pediatric12030029